Skip to main content

Table 3 Tolerance time at LAST interview by patients’ characteristics (n = 167)a

From: Patient preferences of chemotherapy treatment options and tolerance of chemotherapy side effects in advanced stage lung cancer

Variable Category Tolerance time at LAST interview (n = 167)a P-value
No time period(n = 23)
n (%)
Months(n = 84)
n (%)
Years(n = 60)
n (%)
Age group (years) ≤ 60 years 5 (21.7) 16 (19.0) 17 (28.3) 0.5219
61–70 years 7 (30.4) 33 (39.3) 24 (40.0)
> 70 years 11 (47.8) 35 (41.7) 19 (31.7)
Gender Male 14 (60.9) 53 (63.1) 30 (50.0) 0.2794
Female 9 (39.1) 31 (36.9) 30 (50.0)
Race White or Caucasian 21 (91.4) 81 (96.4) 58 (96.6) 0.6112**
Black/African-American 1 (4.4) 1 (1.2) 1 (1.7)
Other 1 (4.4) 2 (2.4) 1 (1.7)
Education Less than high school or high school diploma or GED degree 15 (65.2) 47 (58.0) 27 (45.8) 0.1932
Some college or bachelor’s or higher degree 8 (34.8) 34 (42.0) 32 (54.2)
Employment Working 7 (30.4) 25 (29.8) 15 (25.0) 0.7939
Not working 16 (69.6) 59 (70.2) 45 (75.0)
Marital status Married 12 (52.2) 63 (75.0) 38 (63.3) 0.0780
Not married 11 (47.8) 21 (25.0) 22 (36.7)
Income Annual income $45,000 or more 6 (42.9) 32 (50.8) 16 (40.0) 0.5443
Annual income less than $45,000 8 (57.1) 31 (49.2) 24 (60.0)
Primary method of payment Private insurance 8 (34.8) 31 (36.9) 22 (36.7) 0.6061
Medicare 13 (56.5) 37 (44.1) 24 (40.0)
Medicaid 0 (0.0) 9 (10.7) 9 (15.0)
Others 2 (8.7) 7 (8.3) 5 (8.3)
Urban/Rural Urban 15 (65.2) 59 (70.2) 40 (66.7) 0.8520
Rural 8 (34.8) 25 (29.8) 20 (33.3)
  1. **Uses Fisher’s Exact Test
  2. aExcludes cases where values were not reported (n = 1)